Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid-enhanced MRI? A large-cohort study.
Sarah Poetter-LangRaphael AmbrosAlina MessnerAntonia KristicJacqueline C HodgeNina BastatiWolfgang SchimaVictoria ChernyakMustafa R BashirAhmed Ba-SsalamahPublished in: European radiology (2024)
• There was substantial agreement among the three readers regarding the presence and type of arterial-phase (AP) artifacts, acquisition timing, and lesion visibility. • Impaired AP hypervascular lesion visibility occurred in 17 (3.8%) cases; in eight lesions due to mistiming and in nine lesions due to significant artifacts. • When AP timing was suboptimal, it was too late in 40 exams (3%) and too early in 4 exams (0.2%) of exams.
Keyphrases
- transcription factor
- image quality
- cone beam
- healthcare
- diffusion weighted imaging
- magnetic resonance imaging
- contrast enhanced
- quality improvement
- computed tomography
- liquid chromatography tandem mass spectrometry
- pain management
- ultrasound guided
- magnetic resonance
- mass spectrometry
- gas chromatography
- health insurance